Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
Sanofi announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (…
Sanofi announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (…
Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Xyzal® Allergy 24HR as an over-the-coun…
Sanofi announces that it has successfully priced its offering of EUR 3 billion of notes across 3 tranches: EUR 1.0 bil…
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the Philippines have granted marketing approval to…